Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
08/2000
08/10/2000CA2360688A1 Human t cell effectors expressing cd86 molecule and therapeutic use thereof
08/10/2000CA2360684A1 Method for inducing differentiation into adipocytes, compounds controlling such differentiation and method of screening for same
08/10/2000CA2360670A1 Production of biomedical peptides and proteins in plants using transcomplementation systems
08/10/2000CA2359821A1 Platform for the differentiation of cells
08/10/2000CA2298421A1 Cartilage tissue engineering
08/09/2000EP1026251A2 Transgenic animals expressing human P25
08/09/2000EP1026245A1 Antigen protein and nucleic acid coding for said protein
08/09/2000EP1026173A1 Antihuman thymidylate synthase monoclonal antibodies and hybridomas producing the same
08/09/2000EP1025869A1 Process for the manufacture of stable alginate material
08/09/2000EP1025856A2 Methods for modulating T Cell unresponsiveness
08/09/2000EP1025849A1 Methods for detection and treatment of individuals having abnormal cells expressing HLA-A2/tyrosinase peptide antigens
08/09/2000EP1025262A1 Screening for novel bioactivities
08/09/2000EP1025256A2 Method for identifying binding ligands to receptors
08/09/2000EP1025252A1 Efficient construction of gene targeting vectors
08/09/2000EP1025250A2 Modification of the tocopherol content of transgenic plants
08/09/2000EP1025247A1 In planta method for the production of transgenic plants
08/09/2000EP1025245A2 Rapid generation of stable mammalian cell lines producing high levels of recombinant proteins
08/09/2000EP1025244A2 NOVEL MODIFIED MSP-1 NUCLEIC ACID SEQUENCES AND METHODS FOR INCREASING mRNA LEVELS AND PROTEIN EXPRESSION IN CELL SYSTEMS
08/09/2000EP1025243A2 TRANSCRIPTIONALLY-ACTIVATED AAV INVERTED TERMINAL REPEATS (ITRs) FOR USE WITH RECOMBINANT AAV VECTORS
08/09/2000EP1025241A2 Multiply-substituted protease variants
08/09/2000EP1025240A2 Multiply-substituted protease variants with altered net charge for use in detergents
08/09/2000EP1025239A2 Multiply-substituted protease variants
08/09/2000EP1025238A2 Death associated kinase containing ankyrin repeats (dakar)
08/09/2000EP1025237A2 Human checkpoint kinase, hcds1, compositions and methods
08/09/2000EP1025236A2 Human checkpoint kinase, hcds1, compositions and methods
08/09/2000EP1025233A2 Novel modified nucleic acid sequences and methods for increasing mrna levels and protein expression in cell systems
08/09/2000EP1025232A1 A novel mitogenic cyclin and uses thereof
08/09/2000EP1025231A1 Robo: a family of polypeptides and nucleic acids involved in nerve cell guidance
08/09/2000EP1025227A2 Human toll homologues
08/09/2000EP1025220A1 JMY, A CO-ACTIVATOR FOR p300/CBP, NUCLEIC ACID ENCODING JMY AND USES THEREOF
08/09/2000EP1025216A1 Transgenic animal models for cardiac hypertrophy and uses thereof
08/09/2000EP1025212A2 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities
08/09/2000EP1025208A2 A packaging cell line producing siv-pseudotyped mlv
08/09/2000EP1025207A1 Suspension packing cell lines for retrovirus vectors
08/09/2000EP1025206A1 Cell lines useful for (in vitro) assay for identification of carcinogens
08/09/2000EP1025205A2 (in vitro) differentiation of vascular smooth muscle cells, methods and reagents related thereto
08/09/2000EP1025204A1 Methods and materials for the growth of primate-derived primordial stem cells
08/09/2000EP1025203A1 Impaired brca2 function in cells and non-human transgenic animals
08/09/2000EP1025194A1 Bleaching compositions comprising multiply-substituted protease variants
08/09/2000EP1025129A1 Monoclonal antibody to alpha2-macroglobulin and its use for detecting glucan
08/09/2000EP1025124A1 Low-toxicity human interferon-alpha analogues
08/09/2000EP1025122A1 Fibroblast growth factor with hepatocyte proliferation activity
08/09/2000EP1025121A1 PEPTIDES CAPABLE OF INHIBITING THE INTERACTION BETWEEN PRESENILINS AND THE $g(b)-AMYLOID PEPTIDE OR ITS PRECURSOR
08/09/2000EP1024828A1 NOVEL pheS (BETA)
08/09/2000EP1024821A1 Novel prokaryotic polynucleotides, polypeptides and their uses
08/09/2000EP1018979A4 Chemical cleaning of biological material
08/09/2000EP0941027A4 MSC-megakaryocyte precursor composition and method of isolating MSCS associated with isolated megakaryocytes by isolating megakaryocytes
08/09/2000EP0732915B1 Local delivery of fibrinolysis enhancing agents
08/09/2000EP0690914B1 Allergenic protein and peptides from house dust mite and uses therefor
08/09/2000EP0556171B1 Growth hormone antagonists
08/09/2000EP0544887B1 Media concentrate technology
08/09/2000EP0533846B1 The ciliary neurotrophic factor receptor
08/09/2000CN1262690A Ancrod specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of same
08/09/2000CN1262689A Isolated dendritic cell membrane protein genes
08/09/2000CN1262326A Transgenosis plant containing vergence soy-bean isodynamic calcium modulated protein gene for resisting multiple diseases
08/09/2000CN1055313C Recombinative plasmid for high-efficient expressing HBsAg in cell of mammal
08/09/2000CN1055311C Phytocyte anti-senescence agent (PG)
08/08/2000US6100453 Genetically engineering plants against infection; transforming pear cultivars with a gene which encodes for a lytic protein, recovering hybrid pears which lack sensitivity to plant disease
08/08/2000US6100448 Increasing expression of transgenes in plant cells using insulator elements
08/08/2000US6100445 Hybrid rodent with homogeneity for cytokine mutation; for prevention of apoptosis; antiproliferative agents
08/08/2000US6100444 Nucleotide sequences coding prostate gland protein; for the treatment of prostate cancer
08/08/2000US6100390 Nucleotide sequences coding nematode protein; for the prevention of nematode infection of animals
08/08/2000US6100387 Chimeric polypeptides containing chemokine domains
08/08/2000US6100306 Polymeric microbeads and methods of preparation
08/08/2000US6100243 Method of sensitizing tumor cells with adenovirus E1A
08/08/2000US6100235 Methods of treating immune and inflammatory response with IL-17 receptors
08/08/2000US6100091 Modified acyl-ACP desaturase
08/08/2000US6100088 Viral vaccines
08/08/2000US6100087 Ribozymes targeted to human CCR5 mRNA
08/08/2000US6100076 Amino acid sequence of enzyme which glycosylates an epidermal growth factor domain of a polypeptide with an activated fucose moiety
08/08/2000US6100071 Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production
08/08/2000US6100069 Amino acid sequence of peptidyl-propyl cis/trans isomerase involved in protein folding; for screening bacteriostats, bactericides, and antibiotics; diagnosis and prophylaxis
08/08/2000US6100065 Recombinant polypeptide particles with high immunogenicity; comprises portion of pre-s1 peptide and surface antigen peptide
08/08/2000US6100061 Recombinant cell clone having increased stability in serum- and protein-free medium and a method of recovering the stable cell clone and the production of recombinant proteins by using a stable cell clone
08/08/2000US6100060 Recombinant expression system of polynucleotide encoding a specific amino acid sequence and present in a host cell; for recombinant production of wnt-5b polypeptides important in developmental signal transduction
08/08/2000US6100048 Using a panel of mammalian cells transformed with recombinant expression constructs encoding a variety of melanocortin receptors; contacting cells with compound, detecting binding, and determing if compound inhibits feeding behavior
08/08/2000US6100046 Methods of identifying modulators of alpha9, a novel acetylcholine-gated ion channel receptor subunit
08/08/2000US6100037 Polynucleotide encoding a cyclic nucleotide phosphodiesterase having a specific amino acid sequence; diagnosis, treatment, and prevention of cancer and immune disorders; anticarcinogenic/antidiabetic/antiarthritic agents
08/08/2000US6099841 Include hgf receptor antibodies and fragments thereof; used to treat a pathological liver condition
08/08/2000US6099832 Transplants for myocardial scars
08/08/2000CA2233144C Arf-p19, a novel regulator of the mammalian cell cycle
08/08/2000CA2219795C Modulation of cholesteryl ester transfer protein (cetp) activity
08/08/2000CA2216165C Ndf peptides
08/08/2000CA2071907C Bcrf1 proteins as inhibitors of interferon-y
08/08/2000CA1341082C Method of treating tumor cells by inhibiting growth factor receptor function
08/08/2000CA1341074C Hbv surface antigen particles, prepared by recombinant dna processes, composed of different epitopes, selected from the pre-s and s-peptides as a new vaccine
08/08/2000CA1341073C Vectors and methods for expression of human protein c activity
08/03/2000WO2000045176A2 METHOD OF IDENTIFYING N-TERMINAL proBNP
08/03/2000WO2000045174A1 Whole cell selection utilizing azlactone-functional supports
08/03/2000WO2000044917A1 Inducible expression system for use in plants
08/03/2000WO2000044915A1 Method for conveying bnyvv resistance to sugar beet plants
08/03/2000WO2000044912A1 Manipulating isoprenoid expression
08/03/2000WO2000044908A2 Comp/tsp-1, comp/tsp-2 and other tsp chimeric proteins
08/03/2000WO2000044907A1 Gene encoding flavone synthase
08/03/2000WO2000044906A2 GENES IDENTIFIED AS REQUIRED FOR PROLIFERATION IN $i(ESCHERICHIA COLI)
08/03/2000WO2000044904A1 Basb059 polypeptides from neisseria meningitidis
08/03/2000WO2000044903A1 Platelet-derived growth factor/vascular endothelial growth factor-like growth factor h, and uses thereof
08/03/2000WO2000044901A1 Transcriptional regulation of the human beta3-adrenergic receptor gene
08/03/2000WO2000044900A2 Nucleic-acid binding proteins
08/03/2000WO2000044899A1 Her-2/neu fusion proteins